More Information
Treatment of bovine mastitis with Rifamycin SV
Authors: Coxhead NL, Wanstall RN, Buchanan RSPublication: New Zealand Veterinary Journal, Volume 21, Issue 6, pp 116-122, Jun 1973
Publisher: Taylor and Francis
Animal type: Cattle, Livestock, Production animal, Ruminant
Subject Terms: Animal remedies/veterinary medicines, Antibiotics, Treatment/therapy, Bacterial, Mammary gland/udder, Mastitis, Infectious disease, Disease/defect
Article class: Scientific Article
Abstract: Rifamastene is a water-miscible formulation of the new antibiotic rifamycin SV designed for use as an udder infusion for the treatment of bovine mastitis. Literature reporting the activity and properties of rifamycin SV was recently reviewed by Radaelli et al (1971) from which the following descriptions of the properties, toxicity and udder tolerance are summarized. The rifamycins are a family of antibiotics isolated from the fermentation broth of Streptomyces mediterranei. Rifamycin SV was obtained from one of these substances. It is chemically different from other known antibiotics and is particularly active against Gram-positive micro-organisms and mycobacteria. It was introduced into human clinical practice in 1962 for the treatment of Staphylococcus and other Gram-positive infections. Rifamycin acts as a bactericide attacking micro-organisms in their multiplication phase
Access to the full text of this article is available to members of:
- SciQuest - Complimentary Subscription
Login
Otherwise:
Register for an account